CRC has an immunosuppressive TME which prevents the development of a powerful reaction to ICB therapies. There's As a result an urgent have to discover the techniques reprogram this suppressive TME in order to greatly enhance immunotherapy efficacy. In the current review, we employed CRISPR KO screens to find genes that sensitize CRC to antitumor i